GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Medical Care Technologies MDCE · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$1.1m

FY2022FY2025

Net income

$230,768

FY2022FY2025

Free cash flow

$155,470

FY2022FY2025

Shareholders' equity

$1.9m

FY2022FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022
Revenue$1.1m$656,402$731,971$3.5m
Gross profit$576,121$321,849−$57,237$1.3m
Operating income$238,065$152,985−$381,021$1.1m
Net income$230,768$150,379−$387,506$1.1m
Diluted earnings per share0.000.00-0.000.00

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022
Total assets$1.9m$1.5m$603,456$1.0m
Cash and short-term investments$490,546$52,343$35,388$11,797
Total liabilities$26,679$82,031$69,476$124,011
Debt$10,000$67,674$39,140$27,936
Shareholders' equity$1.9m$1.4m$533,980$921,486
Shares outstanding3,263m3,310m3,210m3,210m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022
Cash from operations$155,470−$616,079$29,912$139,547
Capital spending—−$1−$1−$3
Free cash flow$155,470−$616,080$29,911$139,544

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$200,322$49,819$222,825$478,128$296,175$74,566$389,242$249,011
Gross profit$89,660$2,246$498,198$155,720−$123,927$46,130$178,726$141,424
Operating income$48,059−$40,251$377,541$54,370−$186,817−$7,029$109,133$99,697
Net income$47,798−$41,480$376,115$52,103−$188,575−$8,874$140,600$98,587
Diluted earnings per share0.00-0.000.000.00-0.00-0.000.000.00
Total assets$1.9m$1.9m$1.9m$1.6m$1.4m$1.5m$1.5m$1.4m
Cash and short-term investments$363,799$476,448$490,546$251,684$242,403$86,331$52,343$75,080
Debt$37,778$43,045$10,000$79,233$67,661$67,673$67,674$68,308
Shareholders' equity$1.9m$1.8m$1.9m$1.5m$1.2m$1.4m$1.4m$1.2m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-32.4%——
Operating income-40.0%——
Net income-40.6%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin52.0%36.6%——
Operating margin22.6%18.7%——
Net margin22.1%18.4%——

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022
Price to earnings0.20.5-0.10.0
Price to sales0.00.10.00.0

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return-25%220%-31%-76%14288%5119901%3100%45980%76700%300%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 1000-to-1 reverse split · 25 Aug 2014
  • 2000-to-1 reverse split · 2 Aug 2013
  • 11.5-for-1 split · 25 Sept 2008

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.